# Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity (ULS) in Real-life Setting.

> **NCT05224349** · — · COMPLETED · sponsor: **Ipsen** · enrollment: 121 (actual)

## Conditions studied

- Post-Stroke Chronic Upper Limb Spasticity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05224349
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-09
- **Primary completion:** 2025-04-09
- **Final completion:** 2025-07-04
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05224349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05224349, "Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity (ULS) in Real-life Setting.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05224349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*